News
| AI Drug Discovery Institute Signs MOU for Win-Win Cooperation in AI Drug Development | |
|---|---|
|
관리자
2026-09-15
Curiosys signed an MOU with the KPBMA AI Center for New Drug Development to foster AI drug discovery ecosystems and talents. Both entities agreed to collaborate over five years on AI training programs, technical information sharing, and instructor dispatch. Self-Driving Labs (SDL) are emerging as critical infrastructure for shortening drug discovery cycles and are designated as national strategic technologies. Curiosys will leverage its proprietary lab automation technologies (Celloger, Cellpuri, CPX) and biofoundry supply experience to support this initiative. The partnership aims to provide the high-quality data infrastructure and professional convergence talents essential for global leadership in AI drug development. |
| Previous post | Curiosis at ISCT Asia 2026 |
|---|---|
| Next post | WoTS 2026 |